315 related articles for article (PubMed ID: 22227958)
21. Diluted thrombin time reliably measures low to intermediate plasma dabigatran concentrations.
Božič-Mijovski M; Malmström RE; Malovrh P; Antovic JP; Vene N; Šinigoj P; Mavri A
Ann Clin Biochem; 2016 Jul; 53(Pt 4):446-51. PubMed ID: 26392631
[TBL] [Abstract][Full Text] [Related]
22. Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assays.
Douxfils J; Lessire S; Dincq AS; Hjemdahl P; Rönquist-Nii Y; Pohanka A; Gourdin M; Chatelain B; Dogné JM; Mullier F
Thromb Haemost; 2015 Apr; 113(4):862-9. PubMed ID: 25519251
[TBL] [Abstract][Full Text] [Related]
23. Determination of dabigatran in plasma, serum, and urine samples: comparison of six methods.
Du S; Weiss C; Christina G; Krämer S; Wehling M; Krämer R; Harenberg J
Clin Chem Lab Med; 2015 Jul; 53(8):1237-47. PubMed ID: 25720084
[TBL] [Abstract][Full Text] [Related]
24. Dabigatran monitoring made simple?
Eikelboom JW; Weitz JI
Thromb Haemost; 2013 Sep; 110(3):393-5. PubMed ID: 23884303
[No Abstract] [Full Text] [Related]
25. Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma.
Antovic JP; Skeppholm M; Eintrei J; Boija EE; Söderblom L; Norberg EM; Onelöv L; Rönquist-Nii Y; Pohanka A; Beck O; Hjemdahl P; Malmström RE
Eur J Clin Pharmacol; 2013 Nov; 69(11):1875-81. PubMed ID: 23784008
[TBL] [Abstract][Full Text] [Related]
26. [Dabigatran therapy--perioperative management and interpretation of coagulation tests].
Spannagl M; Bauersachs R; Debus ES; Gawaz M; Gerlach H; Haas S; Hach-Wunderle V; Lindhoff-Last E; Riess H; Schellong S; Schinzel H; Bode C
Hamostaseologie; 2012; 32(4):294-305. PubMed ID: 23114798
[TBL] [Abstract][Full Text] [Related]
27. Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal disease.
Khadzhynov D; Wagner F; Formella S; Wiegert E; Moschetti V; Slowinski T; Neumayer HH; Liesenfeld KH; Lehr T; Härtter S; Friedman J; Peters H; Clemens A
Thromb Haemost; 2013 Apr; 109(4):596-605. PubMed ID: 23389759
[TBL] [Abstract][Full Text] [Related]
28. Thrombelastography detects dabigatran at therapeutic concentrations in vitro to the same extent as gold-standard tests.
Solbeck S; Ostrowski SR; Stensballe J; Johansson PI
Int J Cardiol; 2016 Apr; 208():14-8. PubMed ID: 26826624
[TBL] [Abstract][Full Text] [Related]
29. Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register.
Cini M; Legnani C; Cosmi B; Testa S; Dellanoce C; Paoletti O; Marcucci R; Poli D; Paniccia R; Pengo V; Tripodi A; Palareti G;
Int J Lab Hematol; 2018 Apr; 40(2):229-236. PubMed ID: 29314632
[TBL] [Abstract][Full Text] [Related]
30. Determination of dabigatran in human plasma samples.
Harenberg J; Giese C; Marx S; Krämer R
Semin Thromb Hemost; 2012 Feb; 38(1):16-22. PubMed ID: 22314599
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Accuracy of a Novel Chromogenic Direct Thrombin Inhibitor Assay: Clinical Experiences for Dabigatran Monitoring.
Poli S; Härtig F; Spencer C; Ebner M; Birschmann I; Kuhn J; Faix S; Ziemann U; Häring HU; Lehmann R; Peter A; Hörber S
Thromb Haemost; 2017 Dec; 117(12):2369-2375. PubMed ID: 29212124
[TBL] [Abstract][Full Text] [Related]
32. Interpretation of point-of-care INR results in patients treated with dabigatran.
van Ryn J; Baruch L; Clemens A
Am J Med; 2012 Apr; 125(4):417-20. PubMed ID: 22306274
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous determination of rivaroxaban and dabigatran levels in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Korostelev M; Bihan K; Ferreol L; Tissot N; Hulot JS; Funck-Brentano C; Zahr N
J Pharm Biomed Anal; 2014 Nov; 100():230-235. PubMed ID: 25173108
[TBL] [Abstract][Full Text] [Related]
34. [Hemodialysis to remove anticoagulant dabigatran during emergencies].
Carrizo A; Campbell S
Medicina (B Aires); 2014; 74(2):121-3. PubMed ID: 24736256
[TBL] [Abstract][Full Text] [Related]
35. An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis.
Wilson JA; Goralski KB; Soroka SD; Morrison M; Mossop P; Sleno L; Wang Y; Anderson DR
J Clin Pharmacol; 2014 Aug; 54(8):901-9. PubMed ID: 24846496
[TBL] [Abstract][Full Text] [Related]
36. Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate.
Douxfils J; Dogné JM; Mullier F; Chatelain B; Rönquist-Nii Y; Malmström RE; Hjemdahl P
Thromb Haemost; 2013 Sep; 110(3):543-9. PubMed ID: 23783171
[TBL] [Abstract][Full Text] [Related]
37. Monitoring of dabigatran therapy using Hemoclot(®) Thrombin Inhibitor assay in patients with atrial fibrillation.
Samoš M; Stančiaková L; Ivanková J; Staško J; Kovář F; Dobrotová M; Galajda P; Kubisz P; Mokáň M
J Thromb Thrombolysis; 2015 Jan; 39(1):95-100. PubMed ID: 25103614
[TBL] [Abstract][Full Text] [Related]
38. The use of FEIBA® in the correction of coagulation abnormalities induced by dabigatran.
Khoo TL; Weatherburn C; Kershaw G; Reddel CJ; Curnow J; Dunkley S
Int J Lab Hematol; 2013 Apr; 35(2):222-4. PubMed ID: 23020832
[TBL] [Abstract][Full Text] [Related]
39. From laboratory to clinical practice: Dabigatran effects on thrombin generation and coagulation in patient samples.
Helin TA; Lemponen M; Hjemdahl P; Rönquist-Nii Y; Lassila R; Joutsi-Korhonen L
Thromb Res; 2015 Jul; 136(1):154-60. PubMed ID: 25981140
[TBL] [Abstract][Full Text] [Related]
40. Dabigatran overdose: case report of laboratory coagulation parameters and hemodialysis of an 85-year-old man.
Montaruli B; Erroi L; Vitale C; Berutti S; Cosseddu D; Sivera P; Coglitore R; Marangella M; Migliardi M
Blood Coagul Fibrinolysis; 2015 Mar; 26(2):225-9. PubMed ID: 25629417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
